SCHEMBL25507986

SCHEMBL25507986

C[C@@H]1Cc2cc3c(c(OC#N)c21)CCC3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515114 0.87 — —
SCHEMBL21646767 0.87 — —
SCHEMBL19869343 0.81 NLRP3 (0.32) —
SCHEMBL21646764 0.77 NLRP3 (0.30) —
SCHEMBL25507493 0.74 — —
SCHEMBL21646756 0.73 — —
SCHEMBL25206762 0.71 MAOB (0.40) —
SCHEMBL25209250 0.71 DRD2 (0.34) —
SCHEMBL25198086 0.71 MEN1 (0.38) —
SCHEMBL23674464 0.71 BCHE (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159555-A1 SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS GENENTECH, INC. (US) 2023-05-25 — — US disclosed
US-20230159555-A1 SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS GENENTECH, INC. (US) 2023-05-25 — — US disclosed
Send feedback